Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Cygenica Introduced Novel Drug Conjugate in Glioblastoma Multiforme Treatment
CyGenica has introduced novel drug conjugate for the treatment of Glioblastoma Multiforme.
Stanford Medicine Discovered Novel Radiation Treatment Machine
Stanford Medicine has discovered a novel tumour-targeting radiation therapy machine for cancer treatment.
Purdue University Discovered First-in-class Targeted MicroRNA Therapy
Purdue University researchers have discovered a new cancer therapy that uses microRNA to slow or stop division of cancer cells.
NYUAD Researchers Developed Novel Tumour-targeting Nanospheres to Improve Cancer Diagnosis and Treatment
Researchers at NYU Abu Dhabi (NYUAD) have achieved a significant breakthrough in light-based cancer therapies. They have developed biocompatible and biodegradable nanospheres designed to target tumours.
Sandoz Discovered First-of-its-kind Tyruko® Biosimilar for Multiple Sclerosis
Sandoz has introduced first-of-its-kind Tyruko® (natalizumab-sztn) biosimilar designed specifically for the treatment of relapsing forms of multiple sclerosis.
Avenge Bio Introduced AVB-001, a Novel Cell Therapy
Avenge Bio has introduced AVB-001, a novel cell therapy leveraging the LOCOcyte™ immunotherapy platform.
Zai Lab Introduces Novel Efgartigimod Alfa Injection for Polyneuropathy in China
Zai Lab has introduced an innovative treatment option for patients suffering from chronic inflammatory demyelinating polyneuropathy (CIDP) with the launch of efgartigimod alfa injection, delivered subcutaneously as efgartigimod SC.
Pfizer Launches First-of-its-kind ABRYSVO™ Vaccine for Prevention of Respiratory Syncytial Virus in Pregnant Individuals
Pfizer has introduced the first and only ABRYSVO™ vaccine designed to combat lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth to six months.
89bio Discovered Novel Pegozafermin for Nonalcoholic Steatohepatitis
Pegozafermin stands out as a leading analog of fibroblast growth factor 21 (FGF21) and offers several advantages, including robust histological data, exceptional tolerability, and convenient dosing
Kansas City University Discovered New Cancer Treatment
Researchers at Kansas City University have made a breakthrough in treating pancreatic cancer by repurposing the FDA-approved drug Acipimox, originally designed to treat hyperlipidaemia.
